去甲熊去氧胆酸改善胆管结扎小鼠的胆汁性肾病
本研究在胆总管结扎(CBDL)小鼠模型中探讨去甲熊去氧胆酸(norUDCA)对胆汁性肾病的治疗作用及机制。结果显示,norUDCA喂养的CBDL小鼠血清尿素和尿中性粒细胞明胶酶相关脂质运载蛋白(uNGAL)水平显著降低,尿细胞学正常,肾小管间质性肾炎和肾纤维化显著减轻。norUDCA经广泛代谢形成亲水性更强的产物并在肾脏富集,作者认为norUDCA可能成为胆汁性肾病的药物治疗。
要点
- norUDCA喂养的CBDL小鼠血清尿素和uNGAL水平显著低于对照组。
- norUDCA喂养的CBDL小鼠尿细胞学正常,肾小管间质性肾炎和肾纤维化显著减轻。
- norUDCA在体内广泛代谢为亲水性更强的产物并在肾脏富集。
核心结论
- norUDCA通过形成在肾脏富集的高亲水性代谢产物改善胆汁性肾病,作者认为norUDCA可能代表胆汁性肾病的一种药物治疗。
研究设计与样本
- 研究在8周CBDL小鼠中比较norUDCA喂养(CBDL前或后)与普通饲料喂养,评估血清尿素、尿细胞学、uNGAL、肾脏和肝脏羟脯氨酸含量及基因芯片表达,并全面分析肝脏、肾脏、血清和尿液中的胆汁酸谱。
主要发现
- norUDCA喂养的CBDL小鼠血清尿素和uNGAL水平显著低于对照组。
- norUDCA喂养的CBDL小鼠尿细胞学正常,肾小管间质性肾炎和肾纤维化较对照组显著减轻。
- norUDCA经历广泛代谢产生亲水性更强的化合物,这些化合物在肾脏显著富集。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Severe cholestasis may cause cholemic nephropathy that can be modeled in common bile duct ligated (CBDL) mice. We aimed to explore the therapeutic efficacy and mechanisms of norursodeoxycholic acid (norUDCA) in cholemic nephropathy. METHODS: In 8-week CBDL mice fed with norUDCA (prior or post CBDL) or chow we evaluated serum urea levels, urine cytology and urinary neutrophil gelatinase associated lipocalin (uNGAL), kidney and liver tissue quantification of fibrosis by hydroxyproline content and gene chip expression looking at key genes of inflammation and fibrosis. Moreover, we comprehensively analysed bile acid profiles in liver, kidney, serum and urine samples. RESULTS: NorUDCA-fed CBDL mice had significantly lower serum urea and uNGAL levels and less severe cholemic nephropathy as demonstrated by normal urine cytology, significantly reduced tubulointerstitial nephritis, and renal fibrosis as compared to controls. NorUDCA underwent extensive metabolism to produce even more hydrophilic compounds that were significantly enriched in kidneys. CONCLUSION: NorUDCA ameliorates cholemic nephropathy due to the formation of highly hydrophilic metabolites enriched in kidney. Consequently, norUDCA may represent a medical treatment for cholemic nephropathy. LAY SUMMARY: The term cholemic nephropathy describes renal dysfunction together with characteristic morphological alterations of the kidney in obstructive cholestasis that can be mimicked by ligation of the common bile duct in mice. Feeding the hydrophilic bile acid norUDCA to bile duct ligated mice leads to a significant amelioration of the renal phenotype due to the formation of highly hydrophilic metabolites enriched in the kidney and may therefore represent a medical treatment for cholemic nephropathy.
引用
- Krones E, Eller K, Pollheimer MJ, et al. NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated mice. J Hepatol. 2017. PMID: 28242240. doi:10.1016/j.jhep.2017.02.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。